The center is one of three institutions in the nation participating in the trial, which is testing a vaccine designed to prevent the recurrence of triple-negative breast cancer.
Office of Strategic Communication
The center is one of three institutions in the nation participating in the trial, which is testing a vaccine designed to prevent the recurrence of triple-negative breast cancer.